Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration (Q33956370)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration |
scientific article |
Statements
1 reference
Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration (English)
1 reference
Michael H Schiff
1 reference
Jonathan S Jaffe
1 reference
Bruce Freundlich
1 reference
12 April 2014
1 reference
1 reference
73
1 reference
1549-1551
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference